LYON, France, March 8, 2017 -- EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced that the prestigious Focused Ultrasound Foundation, based in Charlottesville, VA, designated long-term academic French partner INSERM LabTAU a Center of Excellence.
EDAP and INSERM Laboratory of Therapeutic Applications of Ultrasound (LabTAU), in conjunction with the University Hospital Edouard Herriot in Lyon, have been collaborating closely for the past 27 years in the development and use of therapeutic ultrasound in the treatment of kidney stones and localized prostate cancer. These strategic interfaces resulted in the successful marketing of Sonolith®, Ablatherm® Robotic-HIFU and Focal One® worldwide. So far, more than 45,000 prostate cancer patients have been treated using our HIFU technology. EDAP and INSERM LabTAU are currently pursuing on-going development projects using HIFU for therapeutic applications beyond prostate cancer.